Simultaneous determination of four antibiotics in human plasma by high-performance LC-MS/MS: application to therapeutic drug monitoring

被引:2
作者
Liu, Hongchuan [1 ]
Yu, Xiaojia [1 ]
Hu, Ting [1 ]
Han, Feifei [1 ]
An, Zhuoling [1 ]
Zhao, Rui [1 ]
机构
[1] Capital Med Univ, Beijing Chao Yang Hosp, Dept Pharm, Beijing 100020, Peoples R China
关键词
antibiotics; HPLC-MS; MS; human plasma analysis; method validation; therapeutic drug monitoring; INFECTIOUS-DISEASES SOCIETY; MASS-SPECTROMETRY ASSAY; 2016; UPDATE; VORICONAZOLE; MANAGEMENT; GUIDELINES;
D O I
10.4155/bio-2023-0020
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Aimed to simultaneously measure linezolid, voriconazole, cefoperazone and fluconazole in human plasma suitable for therapeutic drug monitoring applications, a robust, rapid and easy-to-use HPLC-MS/MS approach was developed and validated. Materials & methods: Protein precipitation was used to prepare analytes from 100 mu l plasma. HPLC was employed for analyte separation, and quantification was conducted via multiple reaction monitoring in positive ion mode. The methodology was fully validated. Results & conclusion: All four antibiotics were found to be stable under the tested conditions, and accuracy values ranged from 90.96 to 113.25% and CV values were <14.0%. This HPLC-MS/MS method can be used for routine clinical therapeutic drug monitoring of linezolid, voriconazole, cefoperazone and fluconazole simultaneously.
引用
收藏
页码:269 / 282
页数:14
相关论文
共 34 条
[1]   Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper# [J].
Abdul-Aziz, Mohd H. ;
Alffenaar, Jan-Willem C. ;
Bassetti, Matteo ;
Bracht, Hendrik ;
Dimopoulos, George ;
Marriott, Deborah ;
Neely, Michael N. ;
Paiva, Jose-Artur ;
Pea, Federico ;
Sjovall, Fredrik ;
Timsit, Jean F. ;
Udy, Andrew A. ;
Wicha, Sebastian G. ;
Zeitlinger, Markus ;
De Waele, Jan J. ;
Roberts, Jason A. .
INTENSIVE CARE MEDICINE, 2020, 46 (06) :1127-1153
[2]   Determination of voriconazole and co-administered drugs in plasma of pediatric cancer patients using UPLC-MS/MS: A key step towards personalized therapeutics [J].
Al-Ghobashy, Medhat A. ;
Kamal, Samah M. ;
El-Sayed, Ghada M. ;
Attia, Ali K. ;
Nagy, Mohamed ;
ElZeiny, Ahmed ;
Elrakaiby, Marwa T. ;
Nooh, Mohammed M. ;
Abbassi, Maggie ;
Aziz, Ramy K. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2018, 1092 :489-498
[3]   Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children [J].
Allegra, Sarah ;
Fatiguso, Giovanna ;
De Francia, Silvia ;
Favata, Fabio ;
Pirro, Elisa ;
Carcieri, Chiara ;
De Nicolo, Amedeo ;
Cusato, Jessica ;
Di Perri, Giovanni ;
D'Avolio, Antonio .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (01) :197-203
[4]  
[Anonymous], 2011, EMEA/CHMP/EWP/192217/2009 Rev. 1 Corr
[5]   A liquid chromatography-tandem mass spectrometry platform for the routine therapeutic drug monitoring of 14 antibiotics: Application to critically ill pediatric patients [J].
Barco, Sebastiano ;
Mesini, Alessio ;
Barbagallo, Laura ;
Maffia, Angelo ;
Tripodi, Gino ;
Pea, Federico ;
Saffioti, Carolina ;
Castagnola, Elio ;
Cangemi, Giuliana .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2020, 186
[6]   Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients [J].
Boonstra, J. M. ;
Martson, A. G. ;
Sandaradura, I ;
Kosterink, J. G. W. ;
van der Werf, T. S. ;
Marriott, D. J. E. ;
Zijlstra, J. G. ;
Touw, D. J. ;
Alffenaar, J. W. C. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (03)
[7]   Therapeutic drug management of linezolid: a missed opportunity for clinicians? [J].
Cattaneo, Dario ;
Gervasoni, Cristina ;
Cozzi, Valeria ;
Castoldi, Simone ;
Baldelli, Sara ;
Clementi, Emilio .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2016, 48 (06) :728-731
[8]  
Center for Drug Evaluation and Research of the US, 2018, DEP HLTH HUM SERV FO
[9]   Individualized Medication of Voriconazole: A Practice Guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society [J].
Chen, Ken ;
Zhang, Xianglin ;
Ke, Xiaoyan ;
Du, Guanhua ;
Yang, Kehu ;
Zhai, Suodi ;
An, Youzhong ;
Chen, Yaolong ;
Dong, Yalin ;
Guo, Ruichen ;
He, Bei ;
Jiang, Bin ;
Li, Huande ;
Lv, Yuan ;
Ma, Xiaojun ;
Miao, Liyan ;
Wang, Jianmin ;
Wang, Rui ;
Wu, Jiuhong ;
Yang, Linhua ;
Zhan, Siyan ;
Zhang, Jing ;
Zhao, Limei ;
Zhao, Rongsheng ;
Zhao, Zhigang ;
Zhou, Guohua ;
Guo, Yimeng ;
Jin, Haiying ;
Li, Taoyuan ;
Li, Xiaofei ;
Liang, Shuyao ;
Liu, Fang ;
Liu, Wei ;
Liu, Yuanyuan ;
Song, Zaiwei ;
Tang, Huilin ;
Wang, Tiansheng ;
Xu, Xiaohan ;
Yang, Huixia ;
Yi, Zhanmiao .
THERAPEUTIC DRUG MONITORING, 2018, 40 (06) :663-674
[10]  
Chinese Pharmacopoeia Commission, 2020, PEOPLES REPUBLIC CHI